Neurocompute
Updates every 24 hours • Last updated 2026-03-11 02:01:42.659180-04:00
Live

Neurocompute

A living index of Parkinson’s & Alzheimer’s research — ingested, tracked, and ranked. Click any paper to open the full record.

41622480

Treatment of animal models of Alzheimer's disease with extracellular vesicles or exosomes and involvement of microRNAs.

Journal Neural regeneration research Date 2026-01-27 Score 100.0
41599691

The Expanding Role of Non-Coding RNAs in Neurodegenerative Diseases: From Biomarkers to Therapeutic Targets.

Journal Pharmaceuticals (Basel, Switzerland) Date 2026-01-03 Score 96.0
41594924

Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases.

Journal Biology Date 2026-01-20 Score 90.0
41688855

Immunometabolism Reframes Alzheimer's Disease: From Systemic Dysmetabolism to Glial Rewiring.

Journal Cellular and molecular neurobiology Date 2026-02-13 Score 88.0
41654144

Neuroimmune dysregulation in Alzheimer's disease: Mechanisms and therapeutic strategies.

Journal Ageing research reviews Date 2026-02-05 Score 88.0
41648350

Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer's models.

Journal bioRxiv : the preprint server for biology Date 2026-01-21 Score 88.0
41599368

Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer's Disease.

Journal Molecules (Basel, Switzerland) Date 2026-01-16 Score 88.0
41599736

Discontinued BACE1 Inhibitors in Phase II/III Clinical Trials and AM-6494 (Preclinical) Towards Alzheimer's Disease Therapy: Repurposing Through Network Pharmacology and Molecular Docking Approach.

Journal Pharmaceuticals (Basel, Switzerland) Date 2026-01-13 Score 88.0
41602154

Role of FK506 binding protein 51 in central nervous system diseases.

Journal Frontiers in molecular neuroscience Date 2025-01-01 Score 88.0
41656560

Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease.

Journal Journal of Parkinson's disease Date 2026-02-08 Score 82.0
41702332

α-synuclein monoclonal antibodies in Parkinson's disease: A failed promise or unmet potential?

Journal Journal of the neurological sciences Date 2026-03-15 Score 80.0
41717900

Gastrodin and Gastrodigenin as Potential Neuroprotectors for the Treatment of Neurodegenerative Diseases.

Journal The American journal of Chinese medicine Date 2026-02-21 Score 80.0
41699331

Non-canonical cell death in neurodegeneration: emerging mechanisms and therapeutic Frontiers.

Journal Apoptosis : an international journal on programmed cell death Date 2026-02-16 Score 80.0
41697753

The promise of GLP-1 receptor agonists for neurodegenerative diseases.

Journal The Journal of clinical investigation Date 2026-02-16 Score 80.0
41679672

Postoperative cognitive dysfunction and neurodegeneration: From inflammation to precision medicine.

Journal Brain research bulletin Date 2026-02-10 Score 80.0
41666016

LAPTM proteins in neurological disorders - Autophagy-lysosome dysfunction and therapeutic targets: A review.

Journal Biomolecules & biomedicine Date 2026-02-10 Score 80.0
41626944

Advances in Immune Cell Interactions and Natural Compounds Therapeutic Strategies in Alzheimer's Disease.

Journal Phytotherapy research : PTR Date 2026-02-02 Score 80.0
41630642

Single-cell analysis reveals neuroprotective histone deacetylase inhibitor pathways.

Journal Alzheimer's & dementia : the journal of the Alzheimer's Association Date 2026-02-01 Score 80.0
41622469

Photonic biosensing and optogenetic technologies: Emerging therapeutic strategies in neurodegenerative diseases.

Journal Neural regeneration research Date 2026-01-27 Score 80.0
41594831

Neuroimaging and Pathology Biomarkers in Parkinson's Disease and Parkinsonism.

Journal Brain sciences Date 2026-01-19 Score 80.0
41599176

Liraglutide and Exenatide in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Cognitive Outcomes.

Journal Pharmaceutics Date 2026-01-04 Score 79.0
41709060

Molecular insights into glial neuroimmune cross reactivity with CNS antigens and its role in neuroinflammation.

Journal Inflammopharmacology Date 2026-02-19 Score 77.0
41683726

Natural Neurobiological Active Compounds in Parkinson's Disease: Molecular Targets, Signaling Pathways, and Therapeutic Prospects.

Journal International journal of molecular sciences Date 2026-01-28 Score 77.0
41724307

Allosteric control and water-assisted signaling in activated dopamine receptors upon G protein coupling.

Journal International journal of biological macromolecules Date 2026-02-20 Score 75.0
41784914

PAR-1 in Alzheimer's Disease: Pathophysiological Insights and Mechanistic Perspectives.

Journal Current medical science Date 2026-03-05 Score 72.0
41733741

Epigenomic subtypes of late-onset Alzheimer's disease reveal distinct microglial signatures.

Journal Acta neuropathologica Date 2026-02-24 Score 72.0
41709686

Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population.

Journal Current opinion in neurology Date 2026-02-19 Score 72.0
41706377

Neuro-renin-angiotensin-aldosterone system axis in alzheimer's disease: from molecular dysregulation to therapeutic redirection.

Journal Metabolic brain disease Date 2026-02-18 Score 72.0
41700028

Neuropeptide-GPCR Regulation of the Neuroimmune Axis in Neurodegeneration: Mechanisms and Translation.

Journal Bioconjugate chemistry Date 2026-02-17 Score 72.0
41703390

Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies.

Journal CNS drugs Date 2026-02-17 Score 72.0
41697572

Role Shift of Glial Cells from Physiology to Pathology in Alzheimer's Disease: The Regulatory Impact of Exercise.

Journal Neuroscience bulletin Date 2026-02-16 Score 72.0
41698629

Marine-Derived bioactive compounds from Aquaculture: Receptor-Mediated neuroprotection in neurodegenerative disorders.

Journal Brain research Date 2026-02-14 Score 72.0
41690071

Adenosine A₂A receptor as a dual-acting molecular switch: Glial morphological changes and neurovascular tissue remodeling in neuroinflammation and neurodegeneration.

Journal Tissue & cell Date 2026-02-12 Score 72.0
41687786

Neuroinflammation in Alzheimer's Disease: The Role of Obesity, Gut Microbiota, and Therapeutic Potential of Omega-3 Fatty Acids and Neural Stem Cells.

Journal The Journal of nutrition Date 2026-02-11 Score 72.0
41701880

Neuroinflammation and Cellular Senescence in Brain Aging and Neurodegeneration.

Journal Aging and disease Date 2026-02-10 Score 72.0
41718119

Parkinson's Disease: From Gene-Environment Risk to Precision Therapy.

Journal Medical sciences (Basel, Switzerland) Date 2026-02-05 Score 72.0
41642156

Transcranial Photobiomodulation for Neuromodulation of Brain Disorders: A Perspective.

Journal Neuromodulation : journal of the International Neuromodulation Society Date 2026-02-05 Score 72.0
41714304

Unraveling Network Pharmacology-Based Therapeutics of Anthranilate Sulfonamides via Sirtuins/FOXO3a Cascade in Alzheimer's Disease.

Journal Journal of neurochemistry Date 2026-02-01 Score 72.0
41618124

From consortia discovery to biotech creation: An innovative approach to next-gen Alzheimer's drugs.

Journal Alzheimer's & dementia : the journal of the Alzheimer's Association Date 2026-02-01 Score 72.0
41618842

Modulation of Network Plasticity Opens Novel Therapeutic Possibilities in Cancer, Diabetes, and Neurodegeneration.

Journal Advanced science (Weinheim, Baden-Wurttemberg, Germany) Date 2026-01-31 Score 72.0
41727529

Structure-activity landscape of Nurr1 (NR4A2) modulators: medicinal chemistry strategies for neurodegenerative disease intervention.

Journal RSC medicinal chemistry Date 2026-01-29 Score 72.0
41683444

Neuroinflammation as a Central Mechanism in Alzheimer's Disease: Therapeutic Insights from Schiff Base Derivatives.

Journal Molecules (Basel, Switzerland) Date 2026-01-29 Score 72.0
41611039

Unlocking the potential of lipid-based nanoparticles for intranasal drug delivery in Parkinson's disease.

Journal International journal of pharmaceutics Date 2026-01-27 Score 72.0
41597661

Oral Dysbiosis and Neuroinflammation: Implications for Alzheimer's, Parkinson's and Mood Disorders.

Journal Microorganisms Date 2026-01-08 Score 72.0
41599177

Extracellular Vesicles in Alzheimer's Disease: Dual Roles in Pathogenesis, Promising Avenues for Diagnosis and Therapy.

Journal Pharmaceutics Date 2026-01-05 Score 72.0
41657477

Exploring the Gut-Brain Connection: The Role of Microbiota in Alzheimer's Disease Pathogenesis.

Journal Dementia and neurocognitive disorders Date 2026-01-01 Score 72.0
41599628

C16-siRNAs in Focus: Development of ALN-APP, a Promising RNAi-Based Therapeutic for Alzheimer's Disease.

Journal Pharmaceuticals (Basel, Switzerland) Date 2025-12-22 Score 72.0
41624991

Efficacy and safety of repetitive transcranial magnetic stimulation on motor function, depression, and cognitive dysfunction in Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials.

Journal Clinical parkinsonism & related disorders Date 2026-01-01 Score 71.0
41801138

Betulinic acid exacerbates biomolecular condensation of α-synuclein: possible role in Parkinson's disease.

Journal Biomaterials science Date 2026-03-09 Score 70.0
41647067

Neurocognitive Disorders: Systematic Review of Approved (2008-2024) and Pipeline Phase III Medications.

Journal Innovations in clinical neuroscience Date 2025-01-01 Score 69.0